Morgan Stanley »

C4 Therapeutics shares owned by Morgan Stanley

Quarter-by-quarter ownership of C4 Therapeutics (CCCC) shares owned by Morgan Stanley from 13F filings

Historical chart of Morgan Stanley investment in C4 Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including C4 Therapeutics held by Morgan Stanley consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in C4 Therapeutics by Morgan Stanley

Quarter filed Position value Share count Share price at filing
2024-06-30 $5.3M 1.1M 4.62
2024-03-31 $4.2M 514k 8.17
2023-12-31 $1.2M 205k 5.65
2023-09-30 $582k 313k 1.86
2023-06-30 $663k 241k 2.75
2022-12-31 $2.2M 379k 5.90
2022-06-30 $5.1M 456k 11.11
2022-03-31 $16M 658k 24.26
2021-06-30 $11M 276k 37.86
2020-12-31 $302k 9.1k 33.12